Global vaccine patents rise, as data reveals shift in Big Pharma strategy – Life Sciences Intellectual Property Review

Research reveals an increase in global filings in 2024/2025, but concerns remain over the future of vaccine development in the US.
Already registered?

If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE – this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

LSIPR
Newton Media Ltd
Kingfisher House
21-23 Elmfield Road
BR1 1LT
United Kingdom

source
This is a newsfeed from leading technology publications. No additional editorial review has been performed before posting.